| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0008 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.32 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.001 |